RSV, Cancer Risk, Pulmonary Hypertension, Bronchiectasis

from TT HealthWatch · host Christina Acosta

Program notes:1:21 Bronchiectasis treatment2:22 Twenty sites in UK3:20 Medical imaging and cancer risk in kids4:20 3000 hematologic cancers5:20 Consider other types of imaging6:23 Head CT increases risk by 35%7:24 Treating pulmonary arterial hypertension8:24 Improved mortality in another trial9:25 Antibody prevention of RSV in healthy infants10:25 Healthy preterm and full term infants11:25 Argues for use of this antibody globally12:25 Antibodies against antibody didn't compromise13:08 End

Episode metadata supplied by the publisher feed · Published Oct 3, 2025

Embed this episode

Attribution link and audio player

What this episode covers

This week's topics include an RSV antibody for healthy infants, cancer risk and CT in early life, treating pulmonary hypertension early, and medicines for bronchiectasis.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

RSV, Cancer Risk, Pulmonary Hypertension, Bronchiectasis

0:00 13:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TT HealthWatch?

This episode is 13 minutes long.

When was this TT HealthWatch episode published?

This episode was published on October 3, 2025.

Can I download this TT HealthWatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!